Full Text View
Tabular View
No Study Results Posted
Related Studies
18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
This study is currently recruiting participants.
Verified January 2013 by National Institutes of Health Clinical Center (CC)
Study NCT00775268   Information provided by National Institutes of Health Clinical Center (CC)

First Received on October 17, 2008.   Last Updated on May 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
Biopsy
Fluordeoxyglucose F 18
[3'-deoxy-3'-[F-18] fluorothymidine
computed tomography
fine-needle aspiration
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services